The global healthcare industry is facing one of its most pressing challenges—antimicrobial resistance (AMR). As conventional antibiotics steadily lose their effectiveness, the spotlight is shifting toward peptide antibiotics, a promising class of therapeutics offering novel mechanisms of action and improved efficacy against drug-resistant pathogens. This shift is positioning...